Related references
Note: Only part of the references are listed.Targeting regulated cell death (RCD) with small-molecule compounds in cancer therapy: A revisited review of apoptosis, autophagy-dependent cell death and necroptosis
Wei Liu et al.
DRUG DISCOVERY TODAY (2022)
Role of plant derived bioactive compounds against cancer
Arpita Roy et al.
SOUTH AFRICAN JOURNAL OF BOTANY (2022)
Safety and Efficacy of 166Ho Radioembolization in Hepatocellular Carcinoma: The HEPAR Primary Study
Margot T. M. Reinders et al.
JOURNAL OF NUCLEAR MEDICINE (2022)
Attacking the PI3K/Akt/mTOR signaling pathway for targeted therapeutic treatment in human cancer
Le Yu et al.
SEMINARS IN CANCER BIOLOGY (2022)
Amygdalin potentiates the anti-cancer effect of Sorafenib on Ehrlich ascites carcinoma and ameliorates the associated liver damage
Attia Ahmed Attia et al.
SCIENTIFIC REPORTS (2022)
Effect of amygdalin on MCF-7, MDA-MB-231 and T-47D breast cancer cells in the in vitro study
Aleksandra Zielinska et al.
POSTEPY HIGIENY I MEDYCYNY DOSWIADCZALNEJ (2022)
Molecular Imaging of Tumor Microenvironment to Assess the Effects of Locoregional Treatment for Hepatocellular Carcinoma
Quan Chen et al.
HEPATOLOGY COMMUNICATIONS (2022)
Amygdalin Decreases Adhesion and Migration of MDA-MB-231 and MCF-7 Breast Cancer Cell Lines
Bashir Mosayyebi et al.
CURRENT MOLECULAR PHARMACOLOGY (2021)
p53 haploinsufficiency and increased mTOR signalling define a subset of aggressive hepatocellular carcinoma
Yuan-Deng Luo et al.
JOURNAL OF HEPATOLOGY (2021)
Medication Trends for Age-Related Macular Degeneration
Yeon-Kyoung Cho et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Inflammation, It's Regulation and Antiphlogistic Effect of the Cyanogenic Glycoside Amygdalin
Daniela Figurova et al.
MOLECULES (2021)
In-vitro and in-vivo investigation of amygdalin, metformin, and combination of both against doxorubicin on hepatocellular carcinoma
Ahmed M. Mamdouh et al.
LIFE SCIENCES (2021)
From pyroptosis, apoptosis and necroptosis to PANoptosis: A mechanistic compendium of programmed cell death pathways
Yaqiu Wang et al.
COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL (2021)
Activation of mTOR Signaling Pathway in Hepatocellular Carcinoma
Gustavo Ferrin et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Bitter apricot ethanolic extract induces apoptosis through increasing expression of Bax/Bcl-2 ratio and caspase-3 in PANC-1 pancreatic cancer cells
Fatemeh Aamazadeh et al.
MOLECULAR BIOLOGY REPORTS (2020)
Properties of FDA-approved small molecule protein kinase inhibitors: A 2020 update
Robert Roskoski
PHARMACOLOGICAL RESEARCH (2020)
Inhibition of EZH2 Attenuates Sorafenib Resistance by Targeting NOTCH1 Activation-Dependent Liver Cancer Stem Cells via NOTCH1-Related MicroRNAs in Hepatocellular CarcinomaGBM
Shanshan Wang et al.
TRANSLATIONAL ONCOLOGY (2020)
Molecular docking, anti-proliferative activity and induction of apoptosis in human liver cancer cells treated with androstane derivatives: Implication of PI3K/AKT/mTOR pathway
Shahad W. Kattan et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2020)
Targeting apoptosis in cancer therapy
Benedito A. Carneiro et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2020)
New insights on sorafenib resistance in liver cancer with correlation of individualized therapy
Zhang Cheng et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2020)
Dampened VEPH1 activates mTORC1 signaling by weakening the TSC1/TSC2 association in hepatocellular carcinoma
Pingping Dong et al.
JOURNAL OF HEPATOLOGY (2020)
Molecular dynamics simulation, free energy landscape and binding free energy computations in exploration the anti-invasive activity of amygdalin against metastasis
Khattab Al-Khafaji et al.
COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE (2020)
The Role of Methyltransferase NSD2 as a Potential Oncogene in Human Solid Tumors
Rui Chen et al.
ONCOTARGETS AND THERAPY (2020)
Autophagy as a modulator of cell death machinery
Masayuki Noguchi et al.
CELL DEATH & DISEASE (2020)
Artesunate Inhibits Growth of Sunitinib-Resistant Renal Cell Carcinoma Cells through Cell Cycle Arrest and Induction of Ferroptosis
Sascha D. Markowitsch et al.
CANCERS (2020)
Critical Role for AMPK in Metabolic Disease-Induced Chronic Kidney Disease
Florian Juszczak et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
The Power of Phytochemicals Combination in Cancer Chemoprevention
Balsam Rizeq et al.
JOURNAL OF CANCER (2020)
Targeting cancer stem cell pathways for cancer therapy
Liqun Yang et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)
Galectins control MTOR and AMPK in response to lysosomal damage to induce autophagy
Jingyue Jia et al.
AUTOPHAGY (2019)
Targeting mTOR in Acute Lymphoblastic Leukemia
Carolina Simioni et al.
CELLS (2019)
Recent updates and future perspectives about amygdalin as a potential anticancer agent: A review
Jiamin Shi et al.
CANCER MEDICINE (2019)
Comparative assessment of Prunus spinosa L. flower extract in non-neoplastic hepatocytes and hepatoblastoma cells
T. Murati et al.
SOUTH AFRICAN JOURNAL OF BOTANY (2019)
Crosstalk between cancer and immune cells: Role of tumor-associated macrophages in the tumor microenvironment
Jing Wang et al.
CANCER MEDICINE (2019)
Role of Plasma miRNA-501 Expression Profile as a Marker of Hepatocellular Carcinoma (HCC) Progression With Hepatitis C Virus Infection
Mohamed Shedid et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2019)
In vitro and in silico anticancer activity of amygdalin on the SK-BR-3 human breast cancer cell line
Bahman Moradipoodeh et al.
MOLECULAR BIOLOGY REPORTS (2019)
Antitumor Action of Amygdalin on Human Breast Cancer Cells by Selective Sensitization to Oxidative Stress
Muayad Mehdi Abboud et al.
NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL (2019)
A Vascular Endothelial Growth Factor-Dependent Sprouting Angiogenesis Assay Based on an In Vitro Human Blood Vessel Model for the Study of Anti-Angiogenic Drugs
Joris Pauty et al.
EBIOMEDICINE (2018)
Hallmarks of Cancer-Related Newly Prognostic Factors of Oral Squamous Cell Carcinoma
Tomonori Sasahira et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Molecular therapies and precision medicine for hepatocellular carcinoma
Josep M. Llovet et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2018)
Assessment of rabbit spermatozoa characteristics after amygdalin and apricot seeds exposure in vivo
Eduard Kolesar et al.
TOXICOLOGY REPORTS (2018)
Assessment of glutathione/glutathione disulphide ratio and S-glutathionylated proteins in human blood, solid tissues, and cultured cells
Daniela Giustarini et al.
FREE RADICAL BIOLOGY AND MEDICINE (2017)
Effects and Side Effects of Using Sorafenib and Sunitinib in the Treatment of Metastatic Renal Cell Carcinoma
Caroline Randrup Hansen et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Assessment of lipid peroxidation by measuring malondialdehyde (MDA) and relatives in biological samples: Analytical and biological challenges
Dimitrios Tsikas
ANALYTICAL BIOCHEMISTRY (2017)
Natural Products as a Vital Source for the Discovery of Cancer Chemotherapeutic and Chemopreventive Agents
Gordon M. Cragg et al.
MEDICAL PRINCIPLES AND PRACTICE (2016)
PI3K/Akt/mTOR and Ras/Raf/MEK/ERK signaling pathways inhibitors as anticancer agents: Structural and pharmacological perspectives
Vivek Asati et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2016)
Quantification of apoptosis and necroptosis at the single cell level by a combination of Imaging Flow Cytometry with classical Annexin V/propidium iodide staining
Sabine Pietkiewicz et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2015)
Advanced hepatocellular carcinoma and sorafenib: Diagnosis, indications, clinical and radiological follow-up
Stefano Colagrande et al.
WORLD JOURNAL OF HEPATOLOGY (2015)
The mTOR pathway in hepatic malignancies
Mamatha Bhat et al.
HEPATOLOGY (2013)
Role of cell cycle on the cellular uptake and dilution of nanoparticles in a cell population
Jong Ah Kim et al.
NATURE NANOTECHNOLOGY (2012)
Sorafenib and bevacizumab for recurrent metastatic hepatoblastoma: Stable radiographic disease with decreased AFP
Anne M. Marsh et al.
PEDIATRIC BLOOD & CANCER (2012)
Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR Cascade Inhibitors: How Mutations Can Result in Therapy Resistance and How to Overcome Resistance
James A. McCubrey et al.
ONCOTARGET (2012)
Treatment of Advanced Hepatocellular Carcinoma with Emphasis on Hepatic Arterial Infusion Chemotherapy and Molecular Targeted Therapy
Masatoshi Kudo
LIVER CANCER (2012)
Targeting Receptor Tyrosine Kinase Pathways in Hepatocellular Carcinoma
Hung Huynh et al.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2011)
Which is more cost-effective under the MELD system: primary liver transplantation, or salvage transplantation after hepatic resection or after loco-regional therapy for hepatocellular carcinoma within Milan criteria?
Matthew P. Landman et al.
HPB (2011)
MicroRNA, Nutrition, and Cancer Prevention
Sharon A. Ross et al.
ADVANCES IN NUTRITION (2011)
Molecularly targeted therapy in hepatocellular carcinoma
Hung Huynh
BIOCHEMICAL PHARMACOLOGY (2010)
Liver Stem Cells and Hepatocellular Carcinoma
Lopa Mishra et al.
HEPATOLOGY (2009)
Targeting the phosphoinositide 3-kinase pathway in cancer
Pixu Liu et al.
NATURE REVIEWS DRUG DISCOVERY (2009)
Recurrence of hepatocellular carcinoma following liver transplantation - A review of preoperative and postoperative prognostic indicators
Michael A. Zimmerman et al.
ARCHIVES OF SURGERY (2008)
Bevacizumab: An angiogenesis inhibitor for the treatment of solid malignancies
Ted Shih et al.
CLINICAL THERAPEUTICS (2006)
Enzyme and proton-activated prodrugs for a selective cancer therapy
LF Tietze et al.
CURRENT PHARMACEUTICAL DESIGN (2003)
Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method
KJ Livak et al.
METHODS (2001)
Share Paper
